These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 2434106)
1. Inhibition of some new cardiotonic agents by tetrodotoxin. Decker N; Grima M; Schwartz J Arzneimittelforschung; 1986 Oct; 36(10):1461-3. PubMed ID: 2434106 [TBL] [Abstract][Full Text] [Related]
2. Effect of some new cardiotonic agents on synaptosomal sodium uptake. Grima M; Decker N; Schwartz J Arzneimittelforschung; 1986 Oct; 36(10):1457-60. PubMed ID: 3814207 [TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles. Ogawa T; Ohhara H; Tsunoda H; Kuroki J; Shoji T Arzneimittelforschung; 1989 Jan; 39(1):33-7. PubMed ID: 2566308 [TBL] [Abstract][Full Text] [Related]
4. Positive inotropic activity of 5-amino-6-cyano-1,3-dimethyl-1,2,3,4-tetrahydropyrido[2,3-d]pyrim idine-2,4-dione in cardiac muscle from guinea-pig and man. Part 6: Compounds with positive inotropic activity. Heber D; Heers C; Ravens U Pharmazie; 1993 Jul; 48(7):537-41. PubMed ID: 7692456 [TBL] [Abstract][Full Text] [Related]
5. A new milrinone analog: role of binding to A1 adenosine receptor in its positive inotropic effect on isolated guinea pig and rat atria. Floreani M; Borea PA; Gessi S; Mosti L; Fossa P; Dorigo P J Pharmacol Exp Ther; 1997 Nov; 283(2):541-7. PubMed ID: 9353368 [TBL] [Abstract][Full Text] [Related]
6. Electrophysiologic effects of saterinone and milrinone in the isolated guinea pig myocardium. Iven H; Brasch H; Armah BI Arzneimittelforschung; 1988 Sep; 38(9):1298-302. PubMed ID: 2906246 [TBL] [Abstract][Full Text] [Related]
7. Positive inotropic effects of milrinone, sulmazole and AR-L100 on isolated normal and infarcted hearts of the rat. Verrijk R; Vleeming W; van Rooij HH; Wemer J; Porsius AJ Arch Int Pharmacodyn Ther; 1989; 297():7-17. PubMed ID: 2730243 [TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardium. Brunkhorst D; von der Leyen H; Meyer W; Schmidt-Schumacher C; Scholz H Arzneimittelforschung; 1988 Sep; 38(9):1293-8. PubMed ID: 2852013 [TBL] [Abstract][Full Text] [Related]
9. Reduction of adriamycin cardiotoxicity by a new cardiotonic agent. Andreani A; Bossa R; Galatulas I; Ninci MA; Rambaldi M Anticancer Res; 1991; 11(1):375-7. PubMed ID: 2018373 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of a new milrinone analogue. Dorigo P; Fraccarollo D; Santostasi G; Gaion RM; Maragno I; Floreani M; Carpenedo F; Jester M; Mosti L; Schenone P Farmaco; 1994 Jan; 49(1):19-23. PubMed ID: 8185745 [TBL] [Abstract][Full Text] [Related]
11. [Milrinone decreases the positive inotropic response of heart muscle to izadrin]. Bardamova IB; Afanas'ev SA Eksp Klin Farmakol; 1994; 57(4):29-31. PubMed ID: 7950778 [TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase isozyme inhibition, activation of the cAMP system, and positive inotropy mediated by milrinone in isolated guinea pig cardiac muscle. Silver PJ; Harris AL; Canniff PC; Lepore RE; Bentley RG; Hamel LT; Evans DB J Cardiovasc Pharmacol; 1989 Apr; 13(4):530-40. PubMed ID: 2470989 [TBL] [Abstract][Full Text] [Related]
13. In vivo cardiotonic activity of pyridylmethylene-2-indolinones. Andreani A; Locatelli A; Morigi R; Leoni A; Bossa R; Chiericozzi M; Galatulas I Arzneimittelforschung; 1998 Jul; 48(7):727-9. PubMed ID: 9706372 [TBL] [Abstract][Full Text] [Related]
14. Reduction of 4-epiadriamycin cardiotoxicity by milrinone, a new cardiotonic agent. Bossa R; Aresca P; Galatulas I; Ninci M Anticancer Res; 1989; 9(3):605-8. PubMed ID: 2764506 [TBL] [Abstract][Full Text] [Related]
15. [Interaction of amrinone and milrinone with endogenous adenosine in isolated atria of goats]. Dorigo P; Gaion RM; Giacometti A; Marcomini A; Maragno I Cardiologia; 1987 Mar; 32(3):293-9. PubMed ID: 3607800 [No Abstract] [Full Text] [Related]
16. [Potential cardiotonics. 14. Synthesis and in vitro positive inotropic actions of 4-morpholino-5-(4-pyridinyl)pyridine derivatives]. Hagen V; Hagen A; Krause EG; Klauschenz E Pharmazie; 1992 Oct; 47(10):767-9. PubMed ID: 1480654 [TBL] [Abstract][Full Text] [Related]
17. Effects on the sodium channel of some new cardiotonic drugs: the 4-, 5-, and 6-pyridyl-2(1H)-quinolone derivatives. Grima M; Beguin MF; Millanvoye-Van Brussel EM; Decker N; Schwartz J J Cardiovasc Pharmacol; 1988 Sep; 12(3):255-63. PubMed ID: 2464096 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacological characterization of functionalized 2-pyridones structurally related to the cardiotonic agent milrinone. Fossa P; Menozzi G; Dorigo P; Floreani M; Mosti L Bioorg Med Chem; 2003 Nov; 11(22):4749-59. PubMed ID: 14556790 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and cardiotonic activity of novel pyrimidine derivatives: crystallographic and quantum chemical studies. Dorigo P; Fraccarollo D; Santostasi G; Maragno I; Floreani M; Borea PA; Mosti L; Sansebastiano L; Fossa P; Orsini F; Benetollo F; Bombieri G J Med Chem; 1996 Sep; 39(19):3671-83. PubMed ID: 8809156 [TBL] [Abstract][Full Text] [Related]
20. Effects of the new cardiotonic agent sulmazole on the slow inward current of sheep cardiac Purkinje fibres. Achenbach C; Ziskoven R; Wiemer J; Hauswirth O Arzneimittelforschung; 1984; 34(12):1743-9. PubMed ID: 6099128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]